Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pettit

Showing results (431-440 of 659) with videos related to

Pageof 66
Sort By:
Experientia|August 15, 1979
The structure of amoorastatone and the cytotoxic limonoid 12-hydroxyamoorastatinJ Polonsky, Z Varon, C Marazano, et al.
Annals of Emergency Medicine|June 18, 2025
Feasibility of Conducting Real-Time Qualitative Interviews With Emergency Department Patients: Lessons From Lung Cancer Screening ResearchNicholas R Pettit, Erin O'Farrell, Ernest Agorde, et al.
Cancer Research|May 15, 1997
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculatureG G Dark, S A Hill, V E Prise, et al.
The American Journal of Pathology|March 19, 2013
Absence of B cells does not compromise intramembranous bone formation during healing in a tibial injury modelLiza J Raggatt, Kylie A Alexander, Simranpreet Kaur, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
In vitro activities of two antimitotic compounds, pancratistatin and 7-deoxynarciclasine, against Encephalitozoon intestinalis, a microsporidium causing infections in humansM Ouarzane-Amara, J F Franetich, D Mazier, et al.
The Journal of Organic Chemistry|December 7, 2002
Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivativesTomas Hudlicky, Uwe Rinner, David Gonzalez, et al.
Anti-Cancer Drugs|June 1, 1995
The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphomaA Maki, H Diwakaran, B Redman, et al.
Arthritis and Rheumatism|June 30, 2007
Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaBEla Martin, Christelle Capini, Emily Duggan, et al.
BMC Musculoskeletal Disorders|June 1, 2017
Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitisHsu-Wen Tseng, Tibor T Glant, Matthew A Brown, et al.
Cancer Research|February 1, 1992
Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1T M Tuttle, T H Inge, K P Bethke, et al.
Pageof 66

Showing results (431-440 of 659) with videos related to

Sort By:
Pageof 66
Experientia|August 15, 1979
The structure of amoorastatone and the cytotoxic limonoid 12-hydroxyamoorastatinJ Polonsky, Z Varon, C Marazano, et al.
Annals of Emergency Medicine|June 18, 2025
Feasibility of Conducting Real-Time Qualitative Interviews With Emergency Department Patients: Lessons From Lung Cancer Screening ResearchNicholas R Pettit, Erin O'Farrell, Ernest Agorde, et al.
Cancer Research|May 15, 1997
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculatureG G Dark, S A Hill, V E Prise, et al.
The American Journal of Pathology|March 19, 2013
Absence of B cells does not compromise intramembranous bone formation during healing in a tibial injury modelLiza J Raggatt, Kylie A Alexander, Simranpreet Kaur, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
In vitro activities of two antimitotic compounds, pancratistatin and 7-deoxynarciclasine, against Encephalitozoon intestinalis, a microsporidium causing infections in humansM Ouarzane-Amara, J F Franetich, D Mazier, et al.
The Journal of Organic Chemistry|December 7, 2002
Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivativesTomas Hudlicky, Uwe Rinner, David Gonzalez, et al.
Anti-Cancer Drugs|June 1, 1995
The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphomaA Maki, H Diwakaran, B Redman, et al.
Arthritis and Rheumatism|June 30, 2007
Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaBEla Martin, Christelle Capini, Emily Duggan, et al.
BMC Musculoskeletal Disorders|June 1, 2017
Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitisHsu-Wen Tseng, Tibor T Glant, Matthew A Brown, et al.
Cancer Research|February 1, 1992
Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1T M Tuttle, T H Inge, K P Bethke, et al.
Pageof 66